Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 424B5 Offering Prospectus
  13. 8-K Event Material agreement
  14. 424B5 Offering Prospectus
  15. 8-K Event Regulation FD disclosure · Other events
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. 8-K Event Regulation FD disclosure
  20. 4 Insider Changes in Ownership

Page 7 of 41 · 819 filings